Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Intellipharmaceutics Intl in

CUSIP: 458173951 | 3 institutional holders

Quarters

Q2 2018 Q3 2017 Q2 2017 Q1 2017 Q4 2016

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile